OraSure Technologies is a global company dedicated to improving health and wellness by providing access to accurate and essential information. With a focus on understanding human and animal health, the OraSure family of companies offers innovative solutions and services backed by science to address the world's greatest health challenges. Their wide range of products and services includes diagnostics and testing, sampling tools, and services and analysis.

They have a legacy of developing game-changing sampling tools, services, and diagnostics that aim to provide the best answers to critical questions in an easy and enlightening way. OraSure Technologies is also at the forefront of COVID-19 testing solutions. Leveraging their expertise, they have developed convenient and pain-free self-collection devices for molecular sample collection that are widely used in lab-based COVID-19 tests.

They have also received FDA Emergency Use Authorizations for their OMNIgene® ORAL and ORAcollect® RNA collection devices, allowing for unsupervised use in approved at-home test kits. In addition, OraSure has received FDA authorization for their InteliSwab® COVID-19 Rapid Tests, which can be used without a prescription. These tests offer a simple and efficient solution, providing results within 30 minutes using samples self-collected from the lower nostrils.

With a commitment to innovation and addressing complex testing challenges, OraSure Technologies continues to empower individuals and healthcare systems with accurate and actionable health information